A comparison between the Chinese 2008 and the 7th edition AJCC staging systems for nasopharyngeal carcinoma

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 38, Issue 2, 2015, Pages 189-196

  Pan, Jianji ^a   Xu, Yuanji ^a   Qiu, Sufang ^a   Zong, Jingfeng ^a   Guo, Qiaojuan ^a   Zhang, Yu ^a   Lin, Shaojun ^a   Lu, Jiade J ^b  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

comparison; magnetic resonance imaging; nasopharyngeal carcinoma; prognosis; staging system

Indexed keywords

PLATINUM DERIVATIVE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHINESE 2008 STAGING SYSTEM; CLINICAL EVALUATION; COMPARATIVE EFFECTIVENESS; DIAGNOSTIC RADIOLOGIST; DISTANT METASTASIS FREE SURVIVAL; FEMALE; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NASOPHARYNX CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PREDICTIVE VALUE; PROGNOSTIC ASSESSMENT; RETROSPECTIVE STUDY; SEVENTH EDITION OF THE AJCC STAGING SYSTEM; SURVIVAL RATE; ADOLESCENT; CHILD; CHINA; COMPARATIVE STUDY; KAPLAN MEIER METHOD; MORTALITY; NASOPHARYNGEAL NEOPLASMS; PATHOLOGY; PRACTICE GUIDELINE; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHINA; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84926409033     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e31828f5c96     Document Type: Article

References (32)

1. Chan AT. Nasopharyngeal carcinoma. Ann Oncol. 2010;21(suppl 7):308-312.
2. Al-Sarraf M. How we wrote a landmark nasopharyngeal intergroup phase III protocol in North America. J Radiat Oncol. 2012;1:95-98.
3. Lo KW, To KF, Huang DP. Focus on nasopharyngeal carcinoma. Cancer Cell. 2004;5:423-438.
4. Beahrs O, Henson DE, Hulter RVP, et al. American Joint Committee on Cancer: Manual for Staging of Cancer. 4th ed. Philadelphia: JB Lippincott; 1992.
5. Hermanek P, Sobin LH. International Union Against Cancer (UICC): TNM Classification of Malignant Tumours. 4th ed. Berlin, Heidelberg and New York: Springer; 1992.
6. Teo PM, Leung SF, Yu P, et al. A comparison of Hos, International Union Against Cancer, and American Joint Committee stage classifications for nasopharyngeal carcinoma. Cancer. 1991;67:434-439.
7. Min H, Hong M, Ma J, et al. A new staging system for nasopharyngeal carcinoma in China. Int J Radiat Oncol Bio Phys. 1994;30:1037-1042.
8. Chinese Committee for Staging of Nasopharyngeal Carcinoma. Report on revision of the Chinese 1992 staging system for nasopharyngeal carcinoma. Available at: http://link.springer.com/article/10.1007/s13566-013-0088-5. Accessed on February 2, 2013.
9. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. 7th ed. Philadephia: Lippincott-Raven; 2009.
10. Gregoire V, Eisbruch A, Hamoir M, et al. Proposal for the delineation of the nodal CTV in the node-positive and the postoperative neck. Radiother Oncol. 2006;79:15-20.
11. Xu LY, Pan JJ, Wu JX, et al. Factors associated with overall survival in 1706 patients with nasopharyngeal carcinoma: significance of intensive neoadjuvant chemotherapy and radiation break. Radiother Oncol. 2010;96:94-99.
12. Lin SJ, Pan JJ, Han L, et al. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys. 2009;75:1071-1078.
13. Ng SH, Chang TC, Ko SF, et al. Nasopharyngeal carcinoma: MRI and CT assessment. Neuroradiology. 1997;39:741-746.
14. Chung NN, Ting LL, Hsu WC, et al. Impact of magnetic resonance imaging versus CT on nasopharyngeal carcinoma: primary tumor target delineation for radiotherapy. Head Neck. 2004;26:241-246.
15. Abdel Razek AAK, King A. MRI and CT of nasopharyngeal carcinoma. Am J Roentgenol. 2012;19:11-18.
16. Liao XB, Mao YP, Liu LZ, et al. How does magnetic resonance imaging influence staging according to AJCC staging system for nasopharyngeal carcinoma compared with computed tomography? Int J Radiat Oncol Biol Phys. 2008;72:1368-1377.
17. Lee AW, Sze WM, Au JS, et al. Treatment results for nasopharyngeal carcinoma in the modern era: The Hong Kong experience. Int J Radiat Oncol Biol Phys. 2005;61:1107-1116.
18. Ozyar E, Yildiz F, Akyol FH, et al. Comparison of AJCC 1998 and 1997 classifications for nasopharyngeal carcinoma. Int J Radiat Oncol Biol phys. 1999;44:1079-1087.
19. Cheng SH, Yen KL, Jian JJ, et al. Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials. Int J Radiat Oncol Biol Phys. 2001;50:717-726.
20. Tham IW, Hee SW, Yeo RM, et al. Treatment of nasopharyngeal carcinoma using intensity modulated radiotherapy: The National Cancer Centre Singapore experience. Int J Radiat Oncol Biol Phys. 2009;75:1481-1486.
21. Chen L, Mao YP, Xie FY, et al. The seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China. Radiother Oncol. 2012;104:331-337.
22. Lee AW, Ng WT, Chan LK, et al. The strength/weakness of the AJCC/UICC staging system (7th edition) for nasopharyngeal cancer and suggestions for future improvement. Oral Oncol. 2012;48:1007-1013.
23. Shen CY, Lu JD, Gu YJ, et al. Prognostic impact of primary tumor volume in patients with nasopharyngeal carcinoma treated by definitive radiation therapy. Laryngoscope. 2008;118:1206-1210.
24. Chen CB, Fei ZD, Pan JJ, et al. Significance of primary tumor volume and T-stage on prognosis in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy. Jpn J Clin Oncol. 2011;10:1093-1098.
25. Lee AW, Lin JC, Ng WT. Current management of nasopharyngeal cancer. Semin Radiat Oncol. 2012;22:233-244.
26. Mao YP, Xie FY, Liu LZ, et al. Re-evaluation of 6th edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement based on magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2009;73:1326-1334.
27. Heng DMK, Wee J, Fong KW, et al. Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal cancer. Cancer. 1999;86:1912-1920.
28. Ng WT, Lee AW, Kan WK, et al. N-staging by magnetic resonance imaging for patients with nasopharyngeal carcinoma: pattern of nodal involvement by radiological levels. Radiother Oncol. 2007;82:70-75.
29. Tang L, Li L, Mao YP, et al. Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma detected by magnetic resonance imaging: prognostic value and staging categories. Cancer. 2008;113:347-354.
30. Tham IW, Hee SW, Yap SP, et al. Retropharyngeal nodal metastasis related to higher rate of distant metastasis in patients with N0 and N1 nasopharyngeal cancer. Head Neck. 2009;31:468-474.
31. Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002;53: 12-22.
32. Kaw MK, Teo PM, Chau RM, et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience. Int J Radiat Oncol Biol Phys. 2004;60:1440-1450.